Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
MULTICENTER STUDY
Gabriele Pagliariccio, Ilenia Di Sario, Laura Capoccia, Marcello D'Elia, Gennaro Bafile, Marco Leopardi, Franco Fiore, Armando Palmieri, Lorenzo Antico, Antonio Antico
BACKGROUND: Carotid near-occlusion (CNO) represents an anatomical-functional condition characterized by severe (more than 90%) internal carotid artery stenosis which can lead to a distal lumen diameter greater or less than 2 mm. CNO can be divided into a less severe subgroup (without lumen full collapse: diameter >2 mm) and a more severe subgroup (with lumen full collapse: diameter <2 mm). The decision for revascularization is still highly debated in Literature. The aim of the present multicenter retrospective study is to analyze the incidence of perioperative (30 days) and follow-up complications in 2 groups of patients with or without distal internal carotid lumen full collapse...
May 2024: Annals of Vascular Surgery
#2
JOURNAL ARTICLE
Koichi Morisaki, Daisuke Matsuda, Atsushi Guntani, Go Kinoshita, Shinichiro Yoshino, Kentaro Inoue, Kenichi Honma, Terutoshi Yamaoka, Shinsuke Mii, Tomoharu Yoshizumi
OBJECTIVE: This study aimed to evaluate treatment outcomes after bypass surgery or endovascular therapy (EVT) in average- and high-risk patients with chronic limb-threatening ischemia (CLTI). METHODS: We retrospectively analyzed multicenter data of patients who underwent infra-inguinal revascularization for CLTI between 2015 and 2022. A high-risk patient was defined as one with estimated 30-day mortality rate ≥ 5% or 2-year survival rate ≤ 50%, as determined by the Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia (SPINACH) calculator...
March 22, 2024: Journal of Vascular Surgery
#3
JOURNAL ARTICLE
Matthew Rockhold, Lauren Kunkel, Jordan L Lacoste, Thomas Szymanski, Paul Rothenberg, Pamela Zimmerman, Samantha Minc
OBJECTIVE: The role of direct oral anticoagulants (DOACs) in chronic limb-threatening ischemia after revascularization is unknown. Current evidence-based guidelines do not provide clear guidance on the role of anticoagulation or the selection of anticoagulant. Current practice is highly varied and based on provider and patient preference. The purpose of this study was to measure the impact of different anticoagulants on the incidence of major adverse limb events (MALEs) after revascularization for chronic limb-threatening ischemia, major adverse cardiovascular events (MACEs), all-cause mortality, and hospitalization for major bleeding events...
January 24, 2024: Journal of Vascular Surgery
#4
JOURNAL ARTICLE
Anders Wanhainen, Isabelle Van Herzeele, Frederico Bastos Goncalves, Sergi Bellmunt Montoya, Xavier Berard, Jonathan R Boyle, Mario D'Oria, Carlota F Prendes, Christos D Karkos, Arkadiusz Kazimierczak, Mark J W Koelemay, Tilo Kölbel, Kevin Mani, Germano Melissano, Janet T Powell, Santi Trimarchi, Nikolaos Tsilimparis, George A Antoniou, Martin Björck, Raphael Coscas, Nuno V Dias, Philippe Kolh, Sandro Lepidi, Barend M E Mees, Timothy A Resch, Jean Baptiste Ricco, Riikka Tulamo, Christopher P Twine, Daniela Branzan, Stephen W K Cheng, Ronald L Dalman, Florian Dick, Jonathan Golledge, Stephan Haulon, Joost A van Herwaarden, Nikola S Ilic, Arkadiusz Jawien, Tara M Mastracci, Gustavo S Oderich, Fabio Verzini, Kak Khee Yeung
OBJECTIVE: The European Society for Vascular Surgery (ESVS) has developed clinical practice guidelines for the care of patients with aneurysms of the abdominal aorta and iliac arteries in succession to the 2011 and 2019 versions, with the aim of assisting physicians and patients in selecting the best management strategy. METHODS: The guideline is based on scientific evidence completed with expert opinion on the matter. By summarising and evaluating the best available evidence, recommendations for the evaluation and treatment of patients have been formulated...
February 2024: European Journal of Vascular and Endovascular Surgery
#5
JOURNAL ARTICLE
David P Ebertz, Saideep Bose, Justin A Smith, Anuja L Sarode, Ravi N Ambani, Jae S Cho, Norman H Kumins, Vikram S Kashyap, Benjamin D Colvard
OBJECTIVE: There is no consensus on the optimal anticoagulant regimen following lower extremity bypass. Historically, warfarin has been utilized for prosthetic or compromised vein bypasses. Direct oral anticoagulants (DOAC) are increasingly replacing warfarin in this context, but their efficacy in bypass preservation has not been well studied. Recent studies have shown that DOACs may improve outcomes following bypasses, however it is unclear if this is dependent upon type of bypass conduit...
November 18, 2023: Journal of Vascular Surgery
#6
JOURNAL ARTICLE
Thomas S Maldonado, Alex Powell, Heiko Wendorff, Jarrad Rowse, Khanjan H Nagarsheth, David J Dexter, Alan M Dietzek, Patrick E Muck, Frank R Arko, Jayer Chung
OBJECTIVE: Acute limb ischemia (ALI) is associated with high rates of amputation and consequent morbidity and mortality. The objective of this study is to report on the safety and efficacy of aspiration thrombectomy using the Indigo Aspiration System in patients with lower extremity (LE) ALI. METHODS: The STRIDE study was an international, multicenter, prospective, study that enrolled 119 participants presenting with LE-ALI. Patients were treated firstline with mechanical thrombectomy using the Indigo Aspiration System, before stenting or angioplasty, or other therapies as determined by treating physician...
November 4, 2023: Journal of Vascular Surgery
#7
JOURNAL ARTICLE
Sebastian Cifuentes, Indrani Sen, Fahad Shuja, Bernardo C Mendes, Jill J Colglazier, Melinda S Schaller, Manju Kalra, Jonathan J Morrison, Randall R DeMartino, Todd E Rasmussen
OBJECTIVE: Patients with chronic limb-threatening ischemia (CLTI) and no great saphenous vein to use as a conduit for arterial bypass have a high risk for amputation despite advances in medical and endovascular therapies. This report presents findings from a U.S. Food and Drug Administration (FDA) supported study of the Human Acellular Vessel (HAV) (Humacyte Inc.) used as a conduit for arterial bypass in patients with CLTI and inadequate or absent autologous conduit. METHODS: The HAV is a 6-mm, 40-cm vessel created from human vascular smooth muscle cells seeded onto a polyglycolic acid scaffold pulsed in a bioreactor for 8 weeks as cells proliferate and the scaffold dissolves...
February 2024: Journal of Vascular Surgery
#8
JOURNAL ARTICLE
Kyungsub Song, Yun Seok Kim, Woo Sung Jang, Suryeun Chung, Yang Hyun Cho, Dong Seop Jeong, Wook Sung Kim, Kiick Sung
BACKGROUND: There is not sufficient evidence of the superiority of hybrid procedures over total arch replacement (TAR) for the aortic arch aneurysm of an elderly patients. This retrospective study aimed to compare total arch replacement and hybrid procedures for treatment of aortic arch aneurysms in patients aged ≥75. METHODS: This study was a multicenter retrospective investigation of peri-operative outcomes of patients undergoing aortic arch aneurysm repair using either TAR or hybrid procedures between January 2012 and May 2021...
August 31, 2023: Journal of Thoracic Disease
#9
Robert Fitridge, Vivienne Chuter, Joseph Mills, Robert Hinchliffe, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J Boyko, Michael S Conte, Misty Humphries, Lee Kirksey, Katharine C McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, David Russell, Jos C van den Berg, Maarit Venermo, Nicolaas Schaper
Diabetes related foot complications have become a major cause of morbidity and are implicated in most major and minor amputations globally. Approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease (PAD) and the presence of PAD significantly increases the risk of adverse limb and cardiovascular events. The International Working Group on the Diabetic Foot (IWGDF) has published evidence based guidelines on the management and prevention of diabetes related foot complications since 1999...
September 14, 2023: Journal of Vascular Surgery
#10
Samuel Leonard, Brett Vernier, Kourosh Keyhani, Arash Keyhani, Akiko Tanaka, S Keisin Wang
A 30-year-old woman presented following a motor vehicle collision with a grade III blunt thoracic aortic injury and an aberrant right subclavian artery. Using intraoperative ultrasound and diagnostic subtraction angiography, we deployed an aortic endograft (cTAG; W.L. Gore & Associates), excluding the injury and aberrant right subclavian artery. The patient immediately lost arterial waveforms in her left arm, confirming incidental coverage of the left subclavian artery, likely due to the polytetrafluoroethylene sheath of the endograft...
September 2023: Journal of Vascular Surgery Cases and Innovative Techniques
#11
JOURNAL ARTICLE
Rebecca Sorber, Chen Dun, Qingwen Kawaji, Christopher J Abularrage, James H Black, Martin A Makary, Caitlin W Hicks
OBJECTIVE: Despite societal guidelines that peripheral vascular intervention (PVI) should not be the first-line therapy for intermittent claudication, a significant number of patients will undergo PVI for claudication within 6 months of diagnosis. The aim of the present study was to investigate the association of early PVI for claudication with subsequent interventions. METHODS: We evaluated 100% of Medicare fee-for-service claims to identify all beneficiaries with a new diagnosis of claudication from January 1, 2015 to December 31, 2017...
March 2023: Journal of Vascular Surgery
#12
JOURNAL ARTICLE
Ngozi Lola Ogunsanya, Ross Milner, Chris L Delaney, Phillip Puckridge
AIMS: The aim of this classification system is to provide vascular surgeons with a simple tool that categorises disease severity by anatomical segment in aortoiliac occlusive disease and thus guide decision making and management strategies. Disease of the common femoral arteries is included as the distal extent of disease with respect to access for both open and endovascular intervention is essential to management planning. METHODS: The classification system designates diseased segment letters and numbers to guide treatment planning...
April 11, 2023: Vascular
#13
JOURNAL ARTICLE
Jonathan Bath, Mario D'Oria, Richard T Rogers, Jill J Colglazier, Drew J Braet, Dawn M Coleman, Salvatore T Scali, Martin R Back, Gregory A Magee, Anastasia Plotkin, Philip Dueppers, Alexander Zimmermann, Rana O Afifi, Sophia Khan, Devin Zarkowsky, Gregory Dyba, Michael C Soult, Carlo Setacci, Massimo Lenti, Loay S Kabbani, Mitchelle R Weaver, Daniele Bissacco, Santi Trimarchi, Jordan B Stoecker, Grace J Wang, Zoltan Szeberin, Eniko Pomozi, Clare Moffatt, Hugh A Gelabert, Shahed Tish, Andrew W Hoel, Nicholas S Cortolillo, Emily L Spangler, Marc A Passman, Giovanni De Caridi, Filippo Benedetto, Wei Zhou, Yousef Abuhakmeh, Daniel H Newton, Christopher M Liu, Giovanni Tinelli, Yamume Tshomba, Airi Katoh, Sammy S Siada, Manar Khashram, Sinead Gormley, John R Mullins, Zachary C Schmittling, Thomas S Maldonado, Amani D Politano, Pawel Rynio, Arkadiusz Kazimierczak, Alexander Gombert, Houman Jalaie, Paolo Spath, Enrico Gallitto, Martin Czerny, Tim Berger, Mark G Davies, Francesco Stilo, Nunzio Montelione, Luca Mezzetto, Gian Franco Veraldi, Sandro Lepidi, Peter Lawrence, Karen Woo
OBJECTIVE: Aberrant Subclavian Artery (ASA) and Kommerell's Diverticulum (KD) are rare vascular anomalies that may be associated with lifestyle-limiting and life-threatening complications. The aim of this study is to report contemporary outcomes after invasive treatment of ASA/KD using a large international dataset. METHODS: Patients who underwent treatment for ASA/KD (2000-2020) were identified through the Vascular Low Frequency Disease Consortium (VLFDC), a multi-institutional collaboration to investigate uncommon vascular disorders...
January 16, 2023: Journal of Vascular Surgery
#14
REVIEW
Sabrina A N Doelare, Thomas W A Koedam, Harm P Ebben, Erik Tournoij, Arjan W J Hoksbergen, Kak K Yeung, Vincent Jongkind
OBJECTIVE: This systematic review and meta-analysis reports the outcomes of catheter directed thrombolysis (CDT) in patients with not immediately threatening (Rutherford I) acute lower limb ischaemia (ALI). DATA SOURCES: PubMed, Embase, and the Cochrane Library. REVIEW METHODS: A systematic search of PubMed, Embase, and the Cochrane Library was performed to identify observational studies and trials published between 1990 and 2022 reporting on the results of CDT in patients with Rutherford I ALI...
April 2023: European Journal of Vascular and Endovascular Surgery
#15
JOURNAL ARTICLE
Shinsuke Mii, Atsushi Guntani, Sho Yamashita, Masaru Ishida
OBJECTIVE: To investigate the association of the intra-operative flow waveform and the flow volume with graft prognosis of the infra-inguinal vein bypass. METHODS: This was a retrospective study of intra-operative flowmetry performed for infra-inguinal autologous vein bypass between 2011 and 2020. Flow waveforms were classified as type 0 - IV according to the Kyushu University (KU) classification. The patients (n = 340) were divided into three groups based on the flow waveform predicting the graft patency: type 0/I (long patency), type II (no early occlusion but late occlusion possible), and type III/IV (early occlusion)...
April 2023: European Journal of Vascular and Endovascular Surgery
#16
RANDOMIZED CONTROLLED TRIAL
Nicholas Govsyeyev, Mark Nehler, Michael S Conte, Sebastian Debus, Jayer Chung, Walter Dorigo, Ivan Gudz, Dainis Krievins, Joseph Mills, Frans Moll, Lars Norgren, Gabriele Piffaretti, Rick Powell, David Szalay, Henrik Sillesen, Max Wohlauer, Michael Szarek, Rupert M Bauersachs, Sonia S Anand, Manesh R Patel, Warren H Capell, Nicole Jaeger, Connie N Hess, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Marc P Bonaca
BACKGROUND: Patients with peripheral artery disease (PAD) requiring lower extremity revascularization (LER) have a high risk of adverse limb and cardiovascular events. The results from the VOYAGER PAD (efficacy and safety of rivaroxaban in reducing the risk of major thrombotic vascular events in subjects with symptomatic peripheral artery disease undergoing peripheral revascularization procedures of the lower extremities) trial have demonstrated that rivaroxaban significantly reduced this risk with an overall favorable net benefit for patients undergoing surgical revascularization...
April 2023: Journal of Vascular Surgery
#17
JOURNAL ARTICLE
Eric M Isselbacher, Ourania Preventza, James Hamilton Black, John G Augoustides, Adam W Beck, Michael A Bolen, Alan C Braverman, Bruce E Bray, Maya M Brown-Zimmerman, Edward P Chen, Tyrone J Collins, Abe DeAnda, Christina L Fanola, Leonard N Girardi, Caitlin W Hicks, Dawn S Hui, William Schuyler Jones, Vidyasagar Kalahasti, Karen M Kim, Dianna M Milewicz, Gustavo S Oderich, Laura Ogbechie, Susan B Promes, Elsie Gyang Ross, Marc L Schermerhorn, Sabrina Singleton Times, Elaine E Tseng, Grace J Wang, Y Joseph Woo
AIM: The "2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance of patients with aortic disease across its multiple clinical presentation subsets (ie, asymptomatic, stable symptomatic, and acute aortic syndromes). METHODS: A comprehensive literature search was conducted from January 2021 to April 2021, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline...
December 13, 2022: Circulation
#18
JOURNAL ARTICLE
Sanjay Divakaran, Sahil A Parikh, Beau M Hawkins, Siyan Chen, Yang Song, Subhash Banerjee, Kenneth Rosenfield, Eric A Secemsky
BACKGROUND: Intravascular ultrasound (IVUS) has been shown in limited prospective studies to improve procedural outcomes for patients undergoing lower extremity peripheral arterial intervention (PVI). OBJECTIVES: The authors aimed to study temporal trends, practice variation, and associated outcomes with the use of IVUS during PVI among Medicare beneficiaries. METHODS: All PVIs performed from 2016 to 2019 among Medicare beneficiaries aged >65 years were included...
October 24, 2022: JACC. Cardiovascular Interventions
#19
EDITORIAL
Thomas Zeller
No abstract text is available yet for this article.
October 24, 2022: JACC. Cardiovascular Interventions
#20
JOURNAL ARTICLE
Karen Woo, Jeffrey J Siracuse, Kyle Klingbeil, Larry W Kraiss, Nicholas H Osborne, Niten Singh, Tze-Woei Tan, Shipra Arya, Subhash Banerjee, Marc P Bonaca, Thomas Brothers, Michael S Conte, David L Dawson, Young Erben, Benjamin M Lerner, Judith C Lin, Joseph L Mills, Derek Mittleider, Deepak G Nair, Leigh Ann O'Banion, Robert B Patterson, Matthew J Scheidt, Jessica P Simons
The Society for Vascular Surgery appropriate use criteria (AUC) for the management of intermittent claudication were created using the RAND appropriateness method, a validated and standardized method that combines the best available evidence from medical literature with expert opinion, using a modified Delphi process. These criteria serve as a framework on which individualized patient and clinician shared decision-making can grow. These criteria are not absolute. AUC should not be interpreted as a requirement to administer treatments rated as appropriate (benefit outweighs risk)...
July 2022: Journal of Vascular Surgery
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
